Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Insulin
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Aspart-PH20
(insulin aspart/rHuPH20) / Halozyme
Oshadi Icp
(insulin oral) / Oshadi Drug Administration
oral insulin
(ORMD-0801) / Oramed
Ersatta
(mono-pegylated version of C-peptide) / Cebix
Nasulin
(intranasal insulin spray) / CPEX
SAR 161271
/ Sanofi
ultra-rapid-acting recombinant human insulin
(BIOD-123) / Ipsen
